 | Up a level |
2021
Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F., Schmitt, Wolfgang D., Hanusch, Claus, Fasching, Peter A., Luebbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marme, Frederik, Reimer, Toralf, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Sinn, Bruno, V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stoetzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael and Loibl, Sibylle
(2021).
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol., 22 (8).
S. 1151 - 1162.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
2020
Sinn, Marianne, Sinn, Bruno, V, Treue, Denise, Keilholz, Ulrich, Damm, Frederik, Schmuck, Rosa, Lohneis, Philipp, Klauschen, Frederick, Striefler, Jana K., Bahra, Marcus, Blaeker, Hendrik, Bischoff, Sven, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Oettle, Helmut, Riess, Hanno, Budczies, Jan and Denkert, Carsten
(2020).
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
Clin. Cancer Res., 26 (14).
S. 3732 - 3740.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265